{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:19:16Z","timestamp":1788315556029,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-024-01709-y","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T04:02:33Z","timestamp":1724990553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Use of a decision support tool and quick start onboarding tool in individuals with type 1 diabetes using advanced automated insulin delivery: a single-arm multi-phase intervention study"],"prefix":"10.1186","volume":"24","author":[{"given":"Shekhar","family":"Sehgal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"De Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyamin","family":"Grosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Williman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamuran","family":"Turksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magaly","family":"Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Frewen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"issue":"3","key":"1709_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/dom.14273","volume":"23","author":"L Leelarathna","year":"2021","unstructured":"Leelarathna L, Choudhary P, Wilmot EG, Lumb A, Street T, Kar P, et al. Hybrid closed-loop therapy: Where are we in 2021? Diabetes Obes Metab. 2021;23(3):655\u201360.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"1709_CR2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1089\/dia.2021.0319","volume":"24","author":"AL Carlson","year":"2022","unstructured":"Carlson AL, Sherr JL, Shulman DI, Garg SK, Pop-Busui R, Bode BW, Lilenquist DR, Brazg RL, Kaiserman KB, Kipnes MS, Thrasher JR. Safety and glycemic outcomes during the MiniMed\u2122 advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes. Diabetes Technol Ther. 2022;24(3):178\u201389. https:\/\/doi.org\/10.1089\/dia.2021.0319.","journal-title":"Diabetes Technol Ther."},{"issue":"18","key":"1709_CR3","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","volume":"381","author":"SA Brown","year":"2019","unstructured":"Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, et al. Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med. 2019;381(18):1707\u201317.","journal-title":"N Engl J Med"},{"issue":"2","key":"1709_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1210\/endrev\/bnac022","volume":"44","author":"M Phillip","year":"2023","unstructured":"Phillip M, Nimri R, Bergenstal RM, Barnard-Kelly K, Danne T, Hovorka R, et al. Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocr Rev. 2023;44(2):254\u201380.","journal-title":"Endocr Rev"},{"issue":"8","key":"1709_CR5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1089\/dia.2019.0105","volume":"21","author":"LH Messer","year":"2019","unstructured":"Messer LH, Berget C, Forlenza GP. A clinical guide to advanced diabetes devices and closed-loop systems using the CARES paradigm. Diabetes Technol Ther. 2019;21(8):462\u20139.","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"1709_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-015-1185-5","volume":"15","author":"H Lu","year":"2015","unstructured":"Lu H, Holt JB, Cheng YJ, Zhang X, Onufrak S, Croft JB. Population-based geographic access to endocrinologists in the United States, 2012. BMC Health Serv Res. 2015;15(1):1\u201313.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"1709_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41746-020-0221-y","volume":"3","author":"RT Sutton","year":"2020","unstructured":"Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit Med. 2020;3(1):17.","journal-title":"NPJ Digit Med"},{"issue":"9","key":"1709_CR8","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41591-020-1045-7","volume":"26","author":"R Nimri","year":"2020","unstructured":"Nimri R, Battelino T, Laffel LM, Slover RH, Schatz D, Weinzimer SA, et al. Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes. Nat Med. 2020;26(9):1380\u20134.","journal-title":"Nat Med"},{"issue":"7","key":"1709_CR9","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s42255-020-0212-y","volume":"2","author":"NS Tyler","year":"2020","unstructured":"Tyler NS, Mosquera-Lopez CM, Wilson LM, Dodier RH, Branigan DL, Gabo VB, et al. An artificial intelligence decision support system for the management of type 1 diabetes. Nat Metab. 2020;2(7):612\u20139.","journal-title":"Nat Metab"},{"key":"1709_CR10","volume-title":"NZDep2018 index of deprivation, final research report","author":"J Atkinson","year":"2020","unstructured":"Atkinson J, Salmond C, Crampton P. NZDep2018 index of deprivation, final research report. Wellington: University of Otago; 2020."},{"key":"1709_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S2213-8587(22)00319-9","volume":"11","author":"T Battelino","year":"2023","unstructured":"Battelino T, Alexander CM, Amiel SA, Arreaza-Rubin G, Beck RW, Bergenstal RM, et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2023;11:42.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"1709_CR12","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2337\/dc09-9032","volume":"32","author":"AE Kitabchi","year":"2009","unstructured":"Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335\u201343.","journal-title":"Diabetes Care"},{"issue":"1","key":"1709_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2202\/1557-4679.1065","volume":"3","author":"JA Ferreira","year":"2007","unstructured":"Ferreira JA. The Benjamini-Hochberg Method in the Case of Discrete Test Statistics. Int J Biostat. 2007;3(1):11. https:\/\/doi.org\/10.2202\/1557-4679.1065.","journal-title":"Int J Biostat."},{"issue":"1","key":"1709_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/dc13-2112","volume":"37","author":"Nathan DM, Group DER","year":"2014","unstructured":"Nathan DM, Group DER. The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014;37(1):9\u201316.","journal-title":"Diabetes Care"},{"issue":"11","key":"1709_CR15","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.2337\/dc18-1581","volume":"41","author":"RM Bergenstal","year":"2018","unstructured":"Bergenstal RM, Beck RW, Close KL, Grunberger G, Sacks DB, Kowalski A, et al. Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. Diabetes Care. 2018;41(11):2275\u201380.","journal-title":"Diabetes Care"},{"issue":"10155","key":"1709_CR16","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0140-6736(18)31947-0","volume":"392","author":"M Tauschmann","year":"2018","unstructured":"Tauschmann M, Thabit H, Bally L, Allen JM, Hartnell S, Wilinska ME, et al. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. The Lancet. 2018;392(10155):1321\u20139.","journal-title":"The Lancet"},{"key":"1709_CR17","unstructured":"Da Silva J, Lepore G, Battelino T, Arrieta A, Casta\u00f1eda J, Grosman B, et al. Real-world performance of the MiniMed\u2122 780G system: first report of outcomes from 4\u2019120 users. Diabetes Technol Ther 2021(ja)."},{"key":"1709_CR18","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1111\/dom.15023","volume":"25","author":"B Grassi","year":"2023","unstructured":"Grassi B, G\u00f3mez AM, Calliari LE, Franco D, Raggio M, Riera F, et al. Real-world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system. Diabetes, Obes Metab. 2023;25:1688.","journal-title":"Diabetes, Obes Metab"},{"issue":"3","key":"1709_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1089\/dia.2019.0270","volume":"22","author":"E Palisaitis","year":"2020","unstructured":"Palisaitis E, El Fathi A, Von Oettingen JE, Krishnamoorthy P, Kearney R, Jacobs P, et al. The efficacy of basal rate and carbohydrate ratio learning algorithm for closed-loop insulin delivery (artificial pancreas) in youth with type 1 diabetes in a diabetes camp. Diabetes Technol Ther. 2020;22(3):185\u201394.","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"1709_CR20","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.2337\/dc17-1188","volume":"40","author":"E Dassau","year":"2017","unstructured":"Dassau E, Pinsker JE, Kudva YC, Brown SA, Gondhalekar R, Dalla Man C, et al. Twelve-week 24\/7 ambulatory artificial pancreas with weekly adaptation of insulin delivery settings: effect on hemoglobin A1c and hypoglycemia. Diabetes Care. 2017;40(12):1719\u201326.","journal-title":"Diabetes Care"},{"issue":"8","key":"1709_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1089\/dia.2018.0079","volume":"20","author":"MD Breton","year":"2018","unstructured":"Breton MD, Patek SD, Lv D, Schertz E, Robic J, Pinnata J, et al. Continuous glucose monitoring and insulin informed advisory system with automated titration and dosing of insulin reduces glucose variability in type 1 diabetes mellitus. Diabetes Technol Ther. 2018;20(8):531\u201340.","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"1709_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1089\/dia.2020.0301","volume":"23","author":"P Avari","year":"2021","unstructured":"Avari P, Leal Y, Herrero P, Wos M, Jugnee N, Arnoriaga-Rodr\u00edguez M, et al. Safety and feasibility of the PEPPER adaptive bolus advisor and safety system: a randomized control study. Diabetes Technol Ther. 2021;23(3):175\u201386.","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"1709_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1089\/dia.2015.0413","volume":"18","author":"M Reddy","year":"2016","unstructured":"Reddy M, Pesl P, Xenou M, Toumazou C, Johnston D, Georgiou P, et al. Clinical safety and feasibility of the advanced bolus calculator for type 1 diabetes based on case-based reasoning: a 6-week nonrandomized single-arm pilot study. Diabetes Technol Ther. 2016;18(8):487\u201393.","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"1709_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2337\/dc21-0838","volume":"45","author":"A Bisio","year":"2022","unstructured":"Bisio A, Anderson S, Norlander L, O\u2019Malley G, Robic J, Ogyaadu S, et al. Impact of a novel diabetes support system on a cohort of individuals with type 1 diabetes treated with multiple daily injections: a multicenter randomized study. Diabetes Care. 2022;45(1):186\u201393.","journal-title":"Diabetes Care"},{"issue":"3","key":"1709_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/dia.2017.0333","volume":"20","author":"B Grosman","year":"2018","unstructured":"Grosman B, Wu D, Miller D, Lintereur L, Roy A, Parikh N, et al. Sensor-augmented pump-based customized mathematical model for type 1 diabetes. Diabetes Technol Ther. 2018;20(3):207\u201321.","journal-title":"Diabetes Technol Ther"},{"key":"1709_CR26","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1089\/dia.2023.0059","volume":"25","author":"B Matejko","year":"2023","unstructured":"Matejko B, Juza A, Kie\u0107-Wilk B, Cyranka K, Krzy\u017cowska S, Cohen O, et al. One-year follow-up of advanced hybrid closed-loop system in adults with type 1 diabetes previously naive to diabetes technology: The effect of switching to a calibration-free sensor. Diabetes Technol Ther. 2023;25:554.","journal-title":"Diabetes Technol Ther"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01709-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-024-01709-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01709-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T04:03:18Z","timestamp":1724990598000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-024-01709-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1709"],"URL":"https:\/\/doi.org\/10.1186\/s12902-024-01709-y","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by health and disability ethics committee south ref (20\/STH\/214). All participants (or their legal guardian) provided written informed consent prior to enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent for publication"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S.S., S.J. and C. F. have no conflicts of interest to disclose. B.J.W. has previously received research funding from Dexcom, Medtronic and iSENS. M.D.B. has received research funding from Novo Nordisk, Medtronic, Dexcom and Pfizer, research support from Medtronic, Dexcom and SOOIL, and honoraria from Medtronic. The following co-authors have no conflicts of interest (B.G., J.W., N.K., V.G., A.B., M.J., A.W. and B.T.).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"167"}}